GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nipro Corp (OTCPK:NPRRF) » Definitions » Other Operating Expense

Nipro (NPRRF) Other Operating Expense : $1,022 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Nipro Other Operating Expense?

Nipro's Other Operating Expense for the three months ended in Dec. 2023 was $260 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $1,022 Mil.

Nipro's quarterly Other Operating Expense declined from Jun. 2023 ($253 Mil) to Sep. 2023 ($247 Mil) but then increased from Sep. 2023 ($247 Mil) to Dec. 2023 ($260 Mil).

Nipro's annual Other Operating Expense increased from Mar. 2022 ($1,057 Mil) to Mar. 2023 ($1,090 Mil) but then declined from Mar. 2023 ($1,090 Mil) to Mar. 2024 ($994 Mil).


Nipro Other Operating Expense Historical Data

The historical data trend for Nipro's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nipro Other Operating Expense Chart

Nipro Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,001.15 1,023.12 1,057.42 1,090.19 994.44

Nipro Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 276.47 252.73 247.48 259.71 262.16

Nipro Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,022 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nipro Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Nipro's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Nipro (NPRRF) Business Description

Traded in Other Exchanges
Address
3-9-3 Honjo-Nishi Kita-ku, Osaka, JPN, 531-8510
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.

Nipro (NPRRF) Headlines

No Headlines